Joanne Smith-Farrell Insider Trading
Get free email notifications about insider trading for Joanne Smith-Farrell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joanne Smith-Farrell. Joanne Smith-Farrell is a VP Corp Development & Strategy in ORE PHARMACEUTICAL HOLDINGS INC. ($GLGC) and a Chief Business Officer in bluebird bio, Inc. ($BLUE) and a COO, Oncology in bluebird bio, Inc. ($BLUE).
Address: 610 PROFESSIONAL DRIVE GAITHERSBURG 20879 MD
Companies in which Joanne Smith-Farrell is an Insider
bluebird bio, Inc.
Trading Symbol: BLUEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Joanne Smith-Farrell: COO, Oncology, Chief Business Officer
Holdings: 21,896 shares
Current Value: $1,613,735
Latest Transaction: Jan 08 2021
$BLUE Market Capitalization: $2.75B
$BLUE Previous Close: $73.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ORE PHARMACEUTICAL HOLDINGS INC.
Trading Symbol: GLGCIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Joanne Smith-Farrell: VP Corp Development & Strategy
Holdings: 0 shares
Latest Transaction: Nov 09 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Joanne Smith-Farrell
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 08 2021 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 45.46 | 538 | 24,459 | 20,609 | 21.1 K to 20.6 K (-2.54 %) |
Jan 08 2021 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 44.76 | 749 | 33,524 | 21,147 | 21.9 K to 21.1 K (-3.42 %) |
Jan 08 2021 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 44.95 | 42 | 1,888 | 21,896 | 21.9 K to 21.9 K (-0.19 %) |
Dec 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 46.50 | 1 | 47 | 21,938 | 21.9 K to 21.9 K (0.00 %) |
Dec 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 46.50 | 1 | 47 | 21,938 | 21.9 K to 21.9 K (0.00 %) |
Dec 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 46.19 | 37 | 1,709 | 21,939 | 22 K to 21.9 K (-0.17 %) |
Dec 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | COO, Oncology | Sell | S | 46.19 | 37 | 1,709 | 21,939 | 22 K to 21.9 K (-0.17 %) |